First-in-class glucokinase activator (GKA) HuaTangNing (dorzagliatin) was approved in China in September 2022. Since the launch of commercial sales at…
Browsing: BioTech
Steadily Advances Innovation and R&D Revenue Climbs to RMB15.28 Billion Adjusted Non-HKFRS Profit Attributable to the Owners of the Parent…
Healthcare Business Surges 88% in Profit Attributable to Owners of the Parent Genertec Universal Medical Group Company Limited (the Universal…
The Personalized Lifestyle Medicine Institute (PLMI) is excited to bring together researchers, clinicians, industry leaders, and anyone interested in Functional…
In-depth Analysis and Testing Unveil the Leading Brain-Boosting Supplements WholisticResearch, a leading authority in the realm of cognitive enhancement research,…
In addition to helping alleviate a chronic nursing shortage in the United States, immigrant nurses are estimated to spend well…
Essex Bio-Technology Ltd (Essex or the Group, HKG: 1061) today announced the interim results for the six months ended 30…
ACROMETA Group Limited, an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biotechnology,…
Core Healthcare Business[1] revenue remains resilient and the Group has a healthy net cashflow from operating activities for 1H23 of…
Speeding up Domestic Clinical Trials A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics…
CanariaBio, a KOSDAQ-listed and a leading late-stage biotechnology company, announces the successful enrollment completion of a Phase 2 study of…
iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of…
On 27 July 2023, on the eve of the highly anticipated Chengdu FISU World University Games, the Minister of Health…
OMO-103 in Phase 1b clinical trial Peptomyc S.L., a biotech company specialized in the development of protein therapeutics for cancer…
Essex Bio-Technology Ltd (Essex or the Group, HKG: 1061) today announced that a phase 1/2 clinical trial of EB12-20145P (HLX04-O),…
BioGX, a global provider of easy molecular diagnostic solutions, announced accelerated adoption of their high performance Sample-Ready(TM) PCR assay* for…
HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA HanchorBio Inc., a global clinical-stage biotechnology company developing…
Group to focus on expanding network of clinics across northern and southern regions of Peninsular Malaysia DCHealthcare Holdings Berhad, an…
On July 12, Legend Capital’s portfolio company, GKHT Medical Technology Co., Ltd. (GKHT Medical; Stock Code: 301370.SZ), was successfully listed…
CGFNS International announced today that it has appointed Lea Sims, a veteran executive who has held both private and public…